Skip to main content
$267.75 -$1.96 (-0.7%)

04:00 PM EDT on 10/15/21

Penumbra (NYSE:PEN)

CAPS Rating: 1 out of 5

Current Price $267.75 Mkt Cap $9.8B
Open $271.22 P/E Ratio 612.98
Prev. Close $267.75 Div. (Yield) $0.00 (0.0%)
Daily Range $265.93 - $271.22 Volume 117,639
52-Wk Range $163.49 - $320.00 Avg. Daily Vol. 159,924

Caps

How do you think NYSE:PEN will perform against the market?

Add Stock to CAPS Watchlist

All Players

17 Outperform
7 Underperform
 

All-Star Players

5 Outperform
3 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSE:PEN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

DGEN4 (< 20)
Submitted October 19, 2017

A very well-run company that is targeting a growing demographic and creating a new market for its neuro and vascular products. Each of its products is unique and addresses its use in a novel way. This company has performed remarkably well since its… More

volfan84 (90.48)
Submitted July 31, 2019

Spruce Point put out a strong sell rating. I have yet to peruse the report too much, but a quick glance at the financials for PEN did make me think that it appears to be overpriced and does not have wild growth prospects.

NYSE:PEN VS S&P 500 (SPY)

NYSE:PEN Summary

Fools bullish on NYSE:PEN are also bullish on:

Fools bearish on NYSE:PEN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PEN.

Recs

1
Member Avatar volfan84 (90.48) Submitted: 7/31/2019 2:27:08 PM : Underperform Start Price: $166.13 NYSE:PEN Score: -12.40

Spruce Point put out a strong sell rating. I have yet to peruse the report too much, but a quick glance at the financials for PEN did make me think that it appears to be overpriced and does not have wild growth prospects.

Recs

0
Member Avatar TMFTypeoh (96.26) Submitted: 5/23/2018 11:05:32 AM : Outperform Start Price: $157.85 NYSE:PEN Score: +4.52

Impressive company

Recs

1
Member Avatar DGEN4 (< 20) Submitted: 10/19/2017 8:35:26 AM : Outperform Start Price: $94.90 NYSE:PEN Score: +106.66

A very well-run company that is targeting a growing demographic and creating a new market for its neuro and vascular products. Each of its products is unique and addresses its use in a novel way. This company has performed remarkably well since its IPO in 2015 and is a longterm buy.

Leaderboard

Find the members with the highest scoring picks in PEN.

Score Leader

camistocks

camistocks (74.39) Score: +276.83

The Score Leader is the player with the highest score across all their picks in PEN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. camistocks 74.39 4/22/2016 Outperform 5Y $54.47 +390.53% +113.69% +276.83 0 Comment
fivepointEmpire 62.08 5/1/2017 Outperform 5Y $85.45 +212.69% +86.72% +125.97 0 Comment
DGEN4 < 20 10/19/2017 Outperform 5Y $94.90 +181.55% +74.88% +106.66 1 Comment
ResearchLover 83.16 7/24/2018 Outperform 3Y $140.10 +90.71% +58.15% +32.57 0 Comment
RMITRA757 99.29 7/9/2018 Outperform 5Y $142.45 +87.57% +61.15% +26.42 0 Comment
ScratchingBuy 75.93 7/9/2019 Outperform 5Y $161.82 +65.12% +50.71% +14.41 0 Comment
NorteClub 35.34 7/29/2020 Underperform 5Y $211.87 +26.11% +38.35% +12.24 0 Comment
ThePharoah 69.50 6/15/2018 Outperform 5Y $154.65 +72.77% +60.75% +12.02 0 Comment
TheFall2021 83.12 1/21/2021 Underperform 5Y $245.75 +8.72% +15.88% +7.16 0 Comment
salamander1 56.46 7/21/2020 Outperform 5Y $189.23 +41.20% +36.51% +4.69 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PEN.